Maternal phenylketonuria collaborative study, obstetric aspects and outcome

The first 6 years

Reuben Matalon, R. Koch, C. Azen, W. B. Hanley, H. L. Levy, R. Matalon, B. Rouse, F. De La Cruz, C. A. Walla

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Objective: The purpose of this study was to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity associated with maternal hyperphenylalaninemia in women of childbearing age with blood phenylalanine levels >240 μmol/L (>4 mg/dl) on an unrestricted diet. Study design: Two hundred thirteen pregnant women with hyperphenylalaninemia that resulted in 134 live births have been enrolled in the study. Outcome measures were subject to the χ2 test, Fisher exact test, analysis of variance, t test, or Wilcoxon nonparametric test for analysis. Results: Optimal fetal outcome appeared to occur when blood phenylalanine levels <600 μmol/L (<10 mg/dl) were achieved by 8 to 10 weeks' gestation and maintained throughout pregnancy (trimester averages of ≤360 μmol/L (≤6 mg/dl)). Initiation of dietary therapy during the third trimester of pregnancy appears to have little beneficial effect on the fetus. Conclusions: Preconceptual counseling and early entrance into a prenatal care program is essential in achieving optimal fetal outcome in women with hyperphenylalaninemia.

Original languageEnglish (US)
Pages (from-to)1150-1162
Number of pages13
JournalAmerican Journal of Obstetrics and Gynecology
Volume166
Issue number4
StatePublished - 1992
Externally publishedYes

Fingerprint

Maternal Phenylketonuria
Phenylketonurias
Phenylalanine
Obstetrics
Pregnancy Trimesters
Reducing Diet
Prenatal Care
Third Pregnancy Trimester
Live Birth
Counseling
Pregnant Women
Analysis of Variance
Fetus
Mothers
Outcome Assessment (Health Care)
Diet
Morbidity
Pregnancy
Therapeutics

Keywords

  • congenital defects
  • dietary therapy
  • fetus
  • maternal phenylketonuria
  • mental retardation

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Matalon, R., Koch, R., Azen, C., Hanley, W. B., Levy, H. L., Matalon, R., ... Walla, C. A. (1992). Maternal phenylketonuria collaborative study, obstetric aspects and outcome: The first 6 years. American Journal of Obstetrics and Gynecology, 166(4), 1150-1162.

Maternal phenylketonuria collaborative study, obstetric aspects and outcome : The first 6 years. / Matalon, Reuben; Koch, R.; Azen, C.; Hanley, W. B.; Levy, H. L.; Matalon, R.; Rouse, B.; De La Cruz, F.; Walla, C. A.

In: American Journal of Obstetrics and Gynecology, Vol. 166, No. 4, 1992, p. 1150-1162.

Research output: Contribution to journalArticle

Matalon, R, Koch, R, Azen, C, Hanley, WB, Levy, HL, Matalon, R, Rouse, B, De La Cruz, F & Walla, CA 1992, 'Maternal phenylketonuria collaborative study, obstetric aspects and outcome: The first 6 years', American Journal of Obstetrics and Gynecology, vol. 166, no. 4, pp. 1150-1162.
Matalon, Reuben ; Koch, R. ; Azen, C. ; Hanley, W. B. ; Levy, H. L. ; Matalon, R. ; Rouse, B. ; De La Cruz, F. ; Walla, C. A. / Maternal phenylketonuria collaborative study, obstetric aspects and outcome : The first 6 years. In: American Journal of Obstetrics and Gynecology. 1992 ; Vol. 166, No. 4. pp. 1150-1162.
@article{23be4319425341f0ab7af487a0ac5bee,
title = "Maternal phenylketonuria collaborative study, obstetric aspects and outcome: The first 6 years",
abstract = "Objective: The purpose of this study was to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity associated with maternal hyperphenylalaninemia in women of childbearing age with blood phenylalanine levels >240 μmol/L (>4 mg/dl) on an unrestricted diet. Study design: Two hundred thirteen pregnant women with hyperphenylalaninemia that resulted in 134 live births have been enrolled in the study. Outcome measures were subject to the χ2 test, Fisher exact test, analysis of variance, t test, or Wilcoxon nonparametric test for analysis. Results: Optimal fetal outcome appeared to occur when blood phenylalanine levels <600 μmol/L (<10 mg/dl) were achieved by 8 to 10 weeks' gestation and maintained throughout pregnancy (trimester averages of ≤360 μmol/L (≤6 mg/dl)). Initiation of dietary therapy during the third trimester of pregnancy appears to have little beneficial effect on the fetus. Conclusions: Preconceptual counseling and early entrance into a prenatal care program is essential in achieving optimal fetal outcome in women with hyperphenylalaninemia.",
keywords = "congenital defects, dietary therapy, fetus, maternal phenylketonuria, mental retardation",
author = "Reuben Matalon and R. Koch and C. Azen and Hanley, {W. B.} and Levy, {H. L.} and R. Matalon and B. Rouse and {De La Cruz}, F. and Walla, {C. A.}",
year = "1992",
language = "English (US)",
volume = "166",
pages = "1150--1162",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Maternal phenylketonuria collaborative study, obstetric aspects and outcome

T2 - The first 6 years

AU - Matalon, Reuben

AU - Koch, R.

AU - Azen, C.

AU - Hanley, W. B.

AU - Levy, H. L.

AU - Matalon, R.

AU - Rouse, B.

AU - De La Cruz, F.

AU - Walla, C. A.

PY - 1992

Y1 - 1992

N2 - Objective: The purpose of this study was to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity associated with maternal hyperphenylalaninemia in women of childbearing age with blood phenylalanine levels >240 μmol/L (>4 mg/dl) on an unrestricted diet. Study design: Two hundred thirteen pregnant women with hyperphenylalaninemia that resulted in 134 live births have been enrolled in the study. Outcome measures were subject to the χ2 test, Fisher exact test, analysis of variance, t test, or Wilcoxon nonparametric test for analysis. Results: Optimal fetal outcome appeared to occur when blood phenylalanine levels <600 μmol/L (<10 mg/dl) were achieved by 8 to 10 weeks' gestation and maintained throughout pregnancy (trimester averages of ≤360 μmol/L (≤6 mg/dl)). Initiation of dietary therapy during the third trimester of pregnancy appears to have little beneficial effect on the fetus. Conclusions: Preconceptual counseling and early entrance into a prenatal care program is essential in achieving optimal fetal outcome in women with hyperphenylalaninemia.

AB - Objective: The purpose of this study was to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity associated with maternal hyperphenylalaninemia in women of childbearing age with blood phenylalanine levels >240 μmol/L (>4 mg/dl) on an unrestricted diet. Study design: Two hundred thirteen pregnant women with hyperphenylalaninemia that resulted in 134 live births have been enrolled in the study. Outcome measures were subject to the χ2 test, Fisher exact test, analysis of variance, t test, or Wilcoxon nonparametric test for analysis. Results: Optimal fetal outcome appeared to occur when blood phenylalanine levels <600 μmol/L (<10 mg/dl) were achieved by 8 to 10 weeks' gestation and maintained throughout pregnancy (trimester averages of ≤360 μmol/L (≤6 mg/dl)). Initiation of dietary therapy during the third trimester of pregnancy appears to have little beneficial effect on the fetus. Conclusions: Preconceptual counseling and early entrance into a prenatal care program is essential in achieving optimal fetal outcome in women with hyperphenylalaninemia.

KW - congenital defects

KW - dietary therapy

KW - fetus

KW - maternal phenylketonuria

KW - mental retardation

UR - http://www.scopus.com/inward/record.url?scp=0026607030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026607030&partnerID=8YFLogxK

M3 - Article

VL - 166

SP - 1150

EP - 1162

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -